The Efficacy and Safety of Abaloparatide‐SC in Men With Osteoporosis: A Randomized Clinical Trial

Abaloparatide significantly increased bone mineral density (BMD) in women with postmenopausal osteoporosis and decreased risk of vertebral, nonvertebral, and clinical fractures compared with placebo. The Abaloparatide for the Treatment of Men with Osteoporosis (ATOM; NCT03512262) study evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Czerwinski, Edward, Cardona, Jose, Plebanski, Rafal, Recknor, Chris, Vokes, Tamara, Saag, Kenneth G, Binkley, Neil, Lewiecki, E Michael, Adachi, Jonathan, Knychas, Dorota, Kendler, David, Orwoll, Eric, Chen, Yinzhong, Pearman, Leny, Li, Y Heather, Mitlak, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091818/
https://www.ncbi.nlm.nih.gov/pubmed/36190391
http://dx.doi.org/10.1002/jbmr.4719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091818/
https://www.ncbi.nlm.nih.gov/pubmed/36190391
http://dx.doi.org/10.1002/jbmr.4719

Ejemplares similares